Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
MGD-024 by MacroGenics for Hairy Cell Leukemia: Likelihood of Approval
MGD-024 is under clinical development by MacroGenics and currently in Phase I for Hairy Cell Leukemia. According to GlobalData, Phase...
MGD-024 by MacroGenics for Systemic Mastocytosis: Likelihood of Approval
MGD-024 is under clinical development by MacroGenics and currently in Phase I for Systemic Mastocytosis. According to GlobalData, Phase I...
MGD-024 by MacroGenics for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia): Likelihood of Approval
MGD-024 is under clinical development by MacroGenics and currently in Phase I for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic...